1. Field of the Invention
The present invention relates generally to the field of medical devices. Particularly, the present invention relates to devices and methods for placing a sensor at a selected site within the body of a patient. More particularly, the present invention relates to a temperature-compensated in-vivo sensor and an insertion set therefor.
2. Description of the Prior Art
In the past, it was discovered that tight glycemic control in critically ill patients yielded statistically beneficial results in reducing mortality of patients treated in the intensive care unit for more than five days. A study done by Greet Van den Berghe and associates (New England Journal of Medicine, Nov. 8, 2001) showed that using insulin to control blood glucose within the range of 80-110 mg/dL yielded statistically beneficial results in reducing mortality of patients treated in the intensive care unit for more than 5 days from 20.2 percent with conventional therapy to 10.6 percent with intensive insulin therapy. Additionally, intensive insulin control therapy reduced overall in-hospital mortality by 34 percent.
Attempts have been made in the past to monitor various blood analytes using sensors specific for the analytes being monitored. Most methods have involved reversing the direction of blood flow in an infusion line so that blood is pulled out of the patient's circulation at intervals, analyzed and then re-infused back into the patient by changing the direction of flow. A problem encountered in reversing an infusion line for sampling is determining how much blood should be withdrawn in order to be certain that pure, undiluted blood is in contact with the sensor.
U.S. Pat. No. 5,165,406 (1992; Wong) discloses a sensor assembly for a combination infusion fluid delivery system and blood chemistry analysis system. The sensor assembly includes a sensor assembly with each of the assembly electrodes mounted in an electrode cavity in the assembly. The system includes provision for delivering the infusion fluid and measuring blood chemistry during reinfusion of the blood at approximately the same flow rates.
U.S. Pat. No. 7,162,290 (2007; Levin) discloses a method and apparatus for periodically and automatically testing and monitoring a patient's blood glucose level. A disposable testing unit is carried by the patient's body and has a testing chamber in fluid communication with infusion lines and a catheter connected to a patient blood vessel. A reversible peristaltic pump pumps the infusion fluid forwardly into the patient blood vessel and reverses its direction to pump blood into the testing chamber to perform the glucose level test. The presence of blood in the testing chamber is sensed by a LED/photodetector pair or pairs. When the appropriate blood sample is present in the test chamber, a glucose oxidase electrode is energized to obtain the blood glucose level.
Although Levin discloses a method of halting the withdrawal of blood at the proper time so that a pure, undiluted sample is presented to the sensor, the method uses an expensive sensor and risks the possibility of contamination by the infusion process. Additionally, infusion of the flush solution has a diluting effect of the blood in the vicinity of the intravenous catheter and presents a time dependent function as to the frequency at which blood glucose can be measured.
It is also well-known that biosensors are typically calibrated to provide actual measurements at a specific temperature. Measurements obtained from a biosensor are dependent on the temperature of the surroundings. If the temperature of the surroundings changes, an error occurs in the measurement. An increase in temperature increases the slope of the curve of the biosensor and the computed analyte level is lower than the actual analyte level. On the other hand, a decrease in temperature decreases the slope of the curve, which causes the computed analyte level to be higher than the actual analyte level. Thus, a change in temperature of the surroundings causes an error in the computed analyte level.
To compensate for temperature fluctuations, various statistical methods have been devised. Classical statistical methods are based on the sum of squared errors between the instrument and reference analyte measurements. Examples of these types of analyses are regression, analysis of variance and correlation. A disadvantage of these approaches is that they focus on the magnitude of measurement errors and do not distinguish those errors that would be clinically significant in the management of a disease such as diabetes. Error grid analysis was developed to classify measurement errors according to their perceived clinical significance.
A modification to the error grid was later proposed by J. L. Parkes et al. (“A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose,” Diabetes Care, 1997, 20:1034-6) to further discern the clinical relevance of glucose measurement errors. More recently, B. P. Kovatchev et al. (“Evaluating the accuracy of continuous glucose-monitoring sensors: continuous glucose-error grid analysis is illustrated by TheraSense Freestyle Navigator data,” Diabetes Care, 2004, 27:1922-8), proposed an adaptation of error grid analysis for the evaluation of measurement error in the case of continuous glucose sensors.
Receiver operating characteristics (ROC) analysis has been used to assess the ability to detect hypoglycemia and hyperglycemia. In this approach, the sensitivity (percent of true events correctly classified) is compared to one minus the specificity (percent of non-events incorrectly classified). A commonly cited statistic from ROC analysis known as area under the curve (AUC) is commonly cited to describe how well a glucose meter or sensor detects values in the hypoglycemic and hyperglycemic range.
The accuracy of a glucose sensor is often summarized by reporting the percentage of values falling in zone A or B of an error grid, the correlation between sensor and reference glucose values and AUC values of hypoglycemia and hyperglycemia. However, these statistics do not adequately describe and may give inflated notions of the true accuracy of a glucose/analyte sensor. Currently analysis methods for accuracy of continuous glucose sensors focus on “point-by-point” assessments of accuracy and may miss important temporal aspects to the data. Even the proposed continuous error grid is a point-by-point assessment of pairs of consecutive glucose measurements.
Therefore, what is needed is a device that simplifies the measurement apparatus. What is also needed is a device that improves usability and limits the infusion fluid to the level required to clear the intravenous catheter site. What is further needed is a device that simplifies the procedures required of medical personnel to those closely related to existing accepted methods. What is still further needed is a device that accurately measures an analyte such as glucose when the sample temperature varies in real time during the measuring period.
It is an object of the present invention to provide a device that simplifies the components needed for the measurement apparatus. It is another object of the present invention to provide a device that improves usability and simplifies the procedures to those closely related to existing accepted method known to medical personnel. It is a further object of the present invention to provide a device that accurately measures an analyte in a sample fluid even when the sample fluid temperature varies in real-time during the measuring period.
The present invention achieves these and other objectives by providing a temperature-compensated, in-vivo biosensor. In one embodiment, the temperature-compensated, in-vivo sensor includes a sensor assembly having a sensor with a plurality of sensor elements at or near one end (i.e. the distal end), a sensor sheath containing the sensor and a hub connected to the other end of the sensor and/or sensor sheath (i.e. the proximal end). In another embodiment, the temperature-compensated, in-vivo sensor includes a sensor assembly and an insertion set. In still another embodiment, the temperature-compensated, in-vivo sensor includes a sensor assembly configured for use with commercially available catheter insertion devices. The sensor assembly includes a sensor sheath having a diameter substantially similar to a commercially available and conventional catheter insertion needle so that the sensor sheath sealingly engages the distal end of the catheter when the sensor assembly is inserted into the catheter after removal of the insertion needle.
In all embodiments of the present invention, the sensor sheath contains a sensor having a plurality of sensor elements disposed on a sensor shank adjacent a sensor distal end and electrical contacts at or adjacent a sensor proximal end. The plurality of sensor elements includes at least an analyte sensor element, a reference sensor element and a temperature sensor element. The temperature sensor element is a low resistive material such as a RTD sensor, a thermistor, a high resistive material such as amorphous germanium, or any device whose resistance changes with changing temperature. The sensor shank is sealingly embedded within the sensor sheath where the sensor elements are exposed at or adjacent the sensor distal end. The sensor may include one or more sensing elements on one side or on all sides of the sensor shank.
In some embodiments of the present invention, the sensor sheath includes a hub configured for mating with the luer fitting on a catheter. A secondary seal is made at the luer fitting.
The sensor signals are transmitted to a monitor by cabling or by radio waves. Optional signal conditioning electronics may be included to receive the sensor signals by way of electrical leads from the sensor. Either hard wiring or a radio link communicates the sensor signals to a monitor, which processes the sensor signals and displays temperature-compensated analytical values, trends and other patient related data for the measured analyte. A typical analyte is blood glucose. Blood glucose measurements are commonly used to determine insulin dosing in tight glycemic control protocols. Although blood glucose is an important blood component, other analytes are possible to measure within the constructs of the present invention.
In yet another embodiment of the present invention, there is disclosed an in-vivo sensor assembly for measuring an analyte in a fluid in a body. The sensor includes a sheath, a hub having a hub sheath portion and a hub cap connected to the hub sheath portion, and a sensor shank sealingly disposed within the sheath and having a shank distal end and a shank proximal end. The hub sheath portion is sealingly connected to a proximal end of the sheath and the hub cap has a connector receiver port.
The sensor shank includes a plurality of sensor elements at or adjacent the distal end of the in-vivo biosensor. The plurality of sensor elements includes at least an analyte sensor element for generating a signal in response to an analyte concentration in a body, a reference sensor element and a temperature sensor element for determining a temperature of an area adjacent to the analyte sensor element and for temperature compensating of an output of the analyte sensor element. The plurality of sensor elements are disposed adjacent the shank distal end and are exposed to the fluid of the body. The position of the temperature sensor relative to the analyte sensor element is critical for accurate analyte concentration measurements, as discussed later.
The sensor shank also includes a plurality of electrical contacts at or adjacent the proximal end of the in-vivo biosensor. The plurality of electrical contacts electrically couples the plurality of sensor elements to a board, which electrically couples the in-vivo biosensor to measuring electronics for determining the analyte concentration in the sample. Various techniques may be used to electrically couple the electrical contacts/electrical connector pads to a connector board. These include wire bonding, direct wire soldering and the like. The sensor shank may also include one or more contact ears extending substantially parallel to the longitudinal axis of the sensor shank from the shank proximal end. Each contact ear may have one or more electrical connector pads. When a plurality of contact ears is included, each of the plurality of contact ears may have one or more electrical connector pads. In a further embodiment, the plurality of contact ears may optionally be offset from the sensor shank and from each other. In such an embodiment, the offset spacing is configured so that the plurality of contact ears securely holds the connector board while insuring good electrical coupling between the electrical connector pads and the connector board.
The electrical connector pads are electrically coupled to the plurality of sensor elements. In another embodiment, the sensor shank further includes an electrical connector having a shank connector board and an electrical connector receiver coupled to the shank connector board. The shank connector board is captured between the plurality of contact ears. When the shank connector board is captured by the contact ears, the connector pads of the plurality of contact ears are electrically coupled to the electrical connector receiver. The electrical connector and the shank proximal end are disposed within the hub cap such that the connector receiver is aligned with the connector receiver port in the hub cap.
In all embodiments of the present invention, the temperature sensor element is preferably a low-resistive material such as a RTD sensor element, a thermistor, a high-resistive material such as amorphous germanium and the like, or any device whose resistance changes with changing temperature. For a RTD sensor element, it is preferred to have a serially-connected, digitated array of a plurality of parallel and electrically conductive traces disposed on the sensor shank. The temperature sensor element is in thermal contact with the sensor elements and the fluid of the body.
One of the major advantages of the present invention particularly in embodiments configured for intravascular use is that the in-vivo sensor is structurally configured for use in combination with commercially-available IV catheters. This simplifies the procedure required of medical personnel since no additional special techniques are required for inserting the intravenous catheter. No highly specialized training is required since the procedures used by medical personnel to insert the intravascular or subcutaneous sensor are closely related to existing accepted methods. Upon removal of the insertion needle, the sensor assembly of the present invention is simply inserted and locked into place using the luer lock fitting. Because the present invention is configured for use with commercially-available IV catheters, no specially designed or customized insertion tools or devices are required to position the in-vivo sensor in the patient intravascularly. For subcutaneous applications, the use of a catheter is optional and the in-vivo sensor is not structurally restricted for use with and to fit within commercially-available catheters.
Another major advantage of the present invention is the inclusion of a temperature sensor for obtaining accurate analyte measurements. Biosensors are intrinsically sensitive to temperature. Relatively small changes in temperature can affect measurement results on the order of 3-4% per degree Celsius. Many clinical procedures benefit from tight glycemic control provided by an in-vivo continuous glucose monitoring (CGM) sensor. During these procedures, body temperature can fluctuate. In fact, many procedures involve dropping the core body temperature significantly. For example, it is customary during certain invasive thoracic procedures to “ice down” patients from 37° Celsius down to 25-30 Celsius. This induced hypothermia procedure intentionally slows certain autonomic responses. A sensor that is stable and calibrated at a body core temperature of 370 Celsius, is no longer calibrated nor accurate during such a procedure.
For CGM applications where the sensor is subcutaneously implanted approximately 5 to 8 millimeters into the abdomen (or other alternative locations), temperature changes can also have an adverse effect on system accuracy. Subcutaneous CGM patients are more likely healthy and highly mobile patients who may be moving in a changing variety of indoor and outdoor weather conditions. All of this may greatly affect the temperature at which the sensor is operating and, consequently, affecting the precision of the measurement readings that the sensor provides.
By placing a temperature sensing element in exact proximity to the biosensor in the blood flow for intravascular applications and in the tissue for subcutaneous applications, the temperature effect on the biosensor can be measured and the biosensor output can be properly compensated to reflect an accurate analyte concentration. An RTD sensor, preferably a platinum RTD, with a temperature accuracy of 0.1° C. is configured at the distal end of the sensor sheath. In fact, maintaining the temperature sensor within 0.25 mm of the analyte sensor greatly improves overall accuracy of the system.
In a further embodiment of the present invention, the analyte sensor element includes a analyte-selective reagent matrix having a plurality of layers where one of the plurality of layers contains an enzyme that is a substrate of the analyte to be measured and another layer disposed over the layer containing the enzyme that is a composite layer having a plurality of microspheres disposed in a hydrogel. The plurality of microspheres are made of a material having substantially little or no permeability to the analyte and substantially high permeability to oxygen while the hydrogel is made of a material that is permeable to the analyte. The material of the microspheres is preferably polydimethylsiloxane and the hydrogel is preferably one of polyurethane or poly-2-hydroxyethyl methacrylate (PHEMA). In another embodiment, the layer containing the enzyme is a PHEMA layer.
In still another embodiment of the present invention, the reagent matrix on the analyte sensor includes a hydrogel layer disposed on the composite layer. This hydrogel layer may optionally include a catalase. The hydrogel is preferably one of polyurethane or PHEMA.
In a further embodiment of the present invention, the reagent matrix on the analyte sensor includes a semi-permeable layer disposed between the composite layer and the electrically conductive electrode(s) of the analyte sensor.
In another embodiment of the present invention, there is disclosed a method of making an in-vivo analyte sensor having a base, a plurality of electrically conductive electrodes electrically coupled to a plurality of electrically conductive pathways, and an analyte-selective reagent matrix disposed on one of the plurality of electrically conductive electrodes. The reagent matrix is formed by disposing a plurality of layers on one of the electrically conductive electrodes where one layer is a composite layer formed by disposing a plurality of microspheres into a hydrogel and another layer containing an enzyme that is a substrate of the analyte to be measured is disposed between the electrically conductive electrode and the composite layer.
In another embodiment of the present invention, there is disclosed a method for temperature compensating an in-vivo analyte sensor measurement for an in-vivo sensor assembly having a plurality of sensor elements disposed at a distal end of a sensor sheath. The method includes measuring a current generated between an analyte sensor element and a reference sensor element, measuring an operating temperature using a temperature sensor element, determining an analyte concentration corresponding to the measured current, and adjusting the analyte concentration. The preferred algorithm for an in-vivo analyte sensor with an included temperature sensor element is analytically derived and empirically adjusted to provide very good correlation for all changes in analyte and temperature. One such algorithm is as follows:
C
cor
r=E
meas
×R
cal×(1−A(Rt)×(1+B(Ediff×Rcal))
where
Thermoregulation in humans is an important mechanism where the core temperature of the body can be regulated by adjustments in heat loss or heat retention mechanisms at the surface of the body. If the body core is too cold, and heat is to be retained, the body reacts by reducing vascular perfusion at the level of the skin (vasoconstriction) and increasing heat production through mechanisms such as shivering. If the body core is too warm, heat can be released by increasing the blood perfusion at the skin level (vasodilation) and through such mechanisms as sweating. These internal thermoregulation mechanisms are often initiated in combination with other active responses (e.g. adding clothing layers if cold, removing them if too warm) leading to complex, depth and time dependent, thermal gradients between surface and core temperatures that are not easily or accurately predicted by external or remote measurements. Because of thermoregulation caused by internal regulation, other active responses, or both, it is clear that significant thermal gradients exist between the skin, subcutaneous tissues, and body core temperatures. Therefore in the case of an analyte sensor whose performance is affected by temperature and where this performance can be corrected to improve measurement accuracy, the ability to measure temperature as close to the analyte sensing element as possible is of vital importance.
For in-vivo CGM, the measurement of fluctuating core body temperature is critical. As mentioned previously, commonly encountered factors such as surface heat loss, variable environmental conditions, base metabolic rate and daily cycles, medications, and other conditions (such as pregnancy) can increase the daily variability of core temperature significantly away from the stated normal of 98.6° F. (37° C.). In fact, standard normal daily temperature and individual variability in healthy persons can lead to core variations between 96° F. and 100° F. (36° F. to 39° F.). This variability can be increased further by medical conditions, intentional medical interventions, medications, fever, or severe environmental factors.
An individual's core temperature can be increased above normal in situations such as fever, disease, hyperthermia, etc., and can reach dangerous levels at 107° F. (42° C.). It is also not uncommon for patients suffering from hypothermia to have core temperatures in the 90° F. (32° C.) range. There are an increasing number of surgical procedures where the core temperature is intentionally lowered to improve surgical outcomes. These include the fields of neurology (e.g. for stroke recovery, aneurysm repair) and cardiovascular (e.g. bypass and other open heart surgical procedures). In these procedures, intra or extra vascular chillers can be used to reduce the core temperature to nearly 67° F. (20° C.).
For example, measuring glucose and maintaining tight glycemic control is essential to daily health and is especially critical in medical situations where an in-vivo (intravascular or subcutaneous) glucose sensor might be employed. An in-vivo glucose sensor will encounter a wide range of temperatures depending on the patient. For example, the temperature variation can be from 104° F. (40° C.) and above for subjects in high fever to 67° C. (20° C.) for patients undergoing surgical procedures that require chilling. For precise temperature measurement and correction, the temperature must be measured as close to the glucose sensing element as possible.
The preferred embodiment(s) of the present invention is illustrated in
As shown in
Like the illustration in
Turning now to
Turning now to
Sensor assembly 30 positioned within catheter 22 is illustrated in
Luer fitting 23 (i.e. female luer fitting) removably connects to hub 46 of sensor assembly 30 in a similar fashion as standard luer-lock connections are used and known to those of ordinary skill in the art.
Turning now to
Because sensor 60 is positioned within sensor sheath 40, sensor shank 62 may have a characteristic of being rigid or flexible or any degree of rigidity/flexibility. Preferably, sensor shank 62 is flexibly resilient to provide less susceptibility to damage during handling and use when configured for any embodiment of the present invention.
Turning now to
Proximal end 164 widens to form a plurality of contact ears 166. Connected to contact ears 166 is an electrical connector 170. Electrical connector 170 is received into and protected by hub cap 174. Electrical connector 170 includes a shank connector board 171 and an electrical connector receiver 172 that is physically and electrically coupled to shank connector board 171. Hub cap 174 includes a connector receiver port 176 that is positioned within the end of hub cap 174 to align with electrical connector receiver 172 when hub cap 174 is assembled to in-vivo sensor assembly 130. Hub sheath portion 144 includes a shank receiving enclosure 146a and a luer locking portion 146b. Shank receiving enclosure 146a includes a hub surface 148 with an optional perimeter wall 147 extending transversely around a major portion of hub surface 148. Extending away from and opposite hub surface 148 is a tubular portion 145. Tubular portion 145 has a central bore 149a for receiving sheath 140 and an optional notch 149b at hub surface 148 and extending laterally to central bore 149a for receiving part of widened portion 164 to prevent sensor shank 160 from rotating within central bore 149 during assembly. Luer lock portion (luer retention nut) 146b receives tubular portion 145 and is fixedly attached to tubular portion 145 forming luer lock portion 146. Luer lock portion 146 is a male luer fitting (hidden from view) that is structured to attach to a female luer fitting such as those commonly used on needles and catheters.
Turning now to
Turning now to
Typically, thermistor 168b will have a pair of thermistor leads 168c with an insulating coating that is preferably about one micron thick. The insulating coating may also cover thermistor 168b. Alternatively, a separate sheath (not shown) may cover thermistor leads 168c or both thermistor 168b and thermistor leads 168c, which separate sheath may then be used to attach to sensor shank 160 and inserted within sensor sheath 140. Thermistor leads 168c may extend the length of sensor shank 160 and electrically couple to shank connector board 171 as is more clearly shown in
Temperature compensation may be achieved by using a temperature compensation element that corrects for the error in the measurement recorded by the analyte sensor element due to a change in temperature. RTDs tend to have inconsistent interchangeability from one to another for purposes of measuring temperature and, thus, require either calibration of the RTD before use or an algorithm that compensates as best as possible for the interchangeability differences between RTD sensors. Thermistors, on the other hand, have very good interchangeability, are available with thermistor interchangeability of 0.1° C., and can provide relatively accurate temperature measurement because of the interchangeability.
For sensor elements 167 made according to the embodiment of the present invention using an RTD sensor, temperature compensation may be expressed by the following algorithm without calibrating each RTD/sensor. The algorithm has been analytically derived and empirically adjusted to show excellent correction for all changes in analyte (and more particularly glucose) and temperature, given a starting calibration point referred to below as Rcal:
C
cor
r=E
meas
×R
cal×(1−A(Rt)×(1+B(Ediff×Rcal))
where,
Constants A and B are analytically derived and empirically determined based on the configuration of the sensor elements 167. Thus, constants A and B may change as the structure and chemistry of sensor elements 167 changes.
It is contemplated that for use in measuring other analytes, the algorithm may be further analytically derived and empirically adjusted accordingly.
When using a thermistor, temperature compensation is more easily determined due to the interchangeability of the thermistors. A more simplified algorithm has been analytically derived and empirically adjusted to show excellent correction for all changes in analyte (and more particularly glucose) and temperature, given a starting calibration point referred to below as Rcal.
C
corr
=E
meas
×R
cal×((1−C)×Tdelta)
where
The following is one example for fabricating a sensor 60 of the present invention and, more particularly, an analyte sensor.
Sensor Fabrication
Step 1. Obtain a sheet of polyimide film, preferably with a thickness of about 0.002 to 0.004 inches. One option to obtain such a polyimide film is to remove the copper layer from a sheet of polyimide flexible laminate available from E. I. du Pont de Nemours and Company, Cat. No. AP8525 under the trademark Pyralux®. Pyralux® AP double-sided, copper-clad laminate is an all-polyimide composite polyimide film bonded to copper foil. Chemical etching is the preferred method for removing the copper layer. The polyimide sheet will become the polyimide support substrate for the sensor elements 67 of the present invention.
Step 2. Apply liquid photoresist to both sides of the polyimide support substrate, expose the photoresist to UV light in a predefined pattern, and remove the unexposed areas to create a pattern for metal deposition. It should be understood that the preferred embodiment of the present invention has sensor elements 67 on both sides of the support substrate but that a single-sided sensor can also be made and is within the scope of the present invention. It is also understood that isolated electrically-conductive pathways are defined in the pattern between each sensor element 67 and a corresponding electrical contact 65. A single sheet of polyimide support substrate provides a plurality of sensors 60. Typically, one side contains the defined two electrodes per sensor (referred to as the top side) while the opposite side contains the reference and/or counter electrodes (referred to as the backside).
Step 3. Coat both sides with one or more layers of electrically conductive materials by vacuum deposition. Acceptable electrically conductive materials include platinum, gold, and the like. Preferably, platinum with a layer of titanium deposited thereon is used for the present invention. Platinum without the titanium layer is preferably used for forming the digitated, serial array 68a for temperature sensor 68.
Step 4. Remove the photoresist including the electrically conductive material on top of the photoresist surface leaving a pattern of electrically conductive material on the polyimide surfaces.
Step 5. Apply an insulation layer to both sides of the modified polyimide sheet preferably by lamination. The insulation layer is preferably a flexible photoimageable coverlay available from E. I. du Pont de Nemours and Company as Pyralux® PC. Pyralux® PC is a flexible, dry film solder mask used to encapsulate flexible printed circuitry. The dry film can be used as a solder mask by patterning openings using conventional printed circuit exposure and development processes. Unexposed areas can be developed off as explained in the technical information brochure provided by Dupont. For the present invention, Pyralux® PC 1015 was used. Expose the insulation layer to UV light and wash out the unexposed portions of the insulation layer. Thermally cure the remaining insulation layer/dry film. The cured remaining insulation layer serves as not only an insulation layer for the temperature sensor 68 and the electrically-conductive pathways between each sensor element 67 and a corresponding electrical contact 65 but also forms the wells to confine and contain the dispensed layers disclosed below for the analyte sensor(s).
Step 6. This and the remaining steps refer to the analyte sensor(s) only and not the temperature sensor 68. Remove the titanium in the areas exposed by the insulation layer using aqueous hydrofluoric acid, which also conveniently removes any surface contaminants from the previous process.
Step 7. Deposit silver onto the electrodes defined by the electrically conductive material pattern on the backside of the polyimide support substrate, and subsequently convert a portion to silver chloride to create a Ag/AgCl electrode, which will serve as counter and reference electrode.
Step 8. Deposit a semi-permeable membrane to the two electrodes per sensor defined on the top side (i.e. glucose electrode and blank electrode) by electropolymerization.
Step 9. Deposit a hydrogel membrane onto the Ag/AgCl counter and reference electrode on the backside of the sheet by dispensing a predefined amount of hydrogel membrane solution, followed by UV curing and washing.
Step 10. Deposit a poly-2-hydroxyethyl methacrylate (PHEMA) membrane precursor solution onto the two electrodes per sensor defined on the top side, UV cure, wash and dry. It should be understood by those skilled in the art that one of the two electrodes is a glucose electrode and, accordingly, the PHEMA membrane precursor solution for this electrode additionally contains a glucose enzyme, preferably glucose oxidase.
Step 11. Deposit a composite membrane precursor solution onto the glucose electrode and the blank electrode, UV cure and dry. The preparation of the composite membrane precursor solution will now be described. Microspheres are prepared from a material having substantially no or little permeability to glucose but a substantially high permeability to oxygen. The microspheres are preferably prepared from PDMS (polydimethylsiloxane). The microspheres are mixed with a hydrogel precursor that allows the passage of glucose. While polyurethane hydrogels work, a PHEMA precursor is preferred. The ratio of microspheres to hydrogel determines the ratio of the glucose to oxygen permeability. Thus, one of ordinary skill in the art can easily determine the ratio that enables the desired dynamic range of glucose measurement at the required low oxygen consumptions. It should be noted that if a polyurethane hydrogel is used, the membrane is cured by evaporating the solvent instead of using ultraviolet light.
Step 12. Optionally deposit additional PHEMA membrane precursor solution to the glucose and blank electrode, UV cure and dry. This optional step adds catalase that prevents release of hydrogen peroxide to the biological environment, reduces flow rate influence on sensor sensitivity and prevents direct contact of the microspheres surface to the biological environment.
Step 13. Cut the polyimide sheet into individual sensors 60. The individual sensors 60 are then assembled into the sensor sheath 40 according to the preferred embodiments previously described.
Reference electrode 280 includes a silver layer 282 formed over electrically conductive layer 264 and a silver-silver chloride layer 284 formed over silver layer 282. Formed over silver-silver chloride layer 284 is a PHEMA or urethane layer 286.
An example of experimental data with and without temperature correction using one embodiment of the present invention is illustrated in
Temperature is depicted on the right axis and shows an initial temperature of approximately 33° C. until approximately 80 minutes into the test. Thereafter, the temperature is gradually raised to 37° C. After equilibrating at this new temperature point, the temperature is raised to 41° C. where it remains for approximately 60 minutes and then allowed to cool gradually. At the same time the temperature is altered, the sensor is exposed to several glucose concentrations (ranging from 39.2 mg/dl to 323.1 mg/dl), and the response of the glucose sensor is recorded. Glucose concentration is presented on the left axis. In an ideal sensor, the output of the sensor would precisely correlate with the concentration of the glucose (as confirmed by the YSI standard). The YSI standard is the glucose concentration of the same sample as measured with a YSI glucose analyzer (Model 2300 Stat Plus, YSI Inc., Yellow Spring, Ohio). However, temperature is known to affect sensor performance.
Even small fluctuations in temperature can result in glucose measurement variability and should be corrected if one is to present accurate glucose data to the user. In
Although the preferred embodiments of the present invention have been described herein, the above description is merely illustrative. Further modification of the invention herein disclosed will occur to those skilled in the respective arts and all such modifications are deemed to be within the scope of the invention as defined by the appended claims.
This application is a Continuation-in-Part Application of Ser. No. 12/052,985, filed on Mar. 21, 2008.
Number | Date | Country | |
---|---|---|---|
Parent | 12052985 | Mar 2008 | US |
Child | 12503376 | US |